Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

COVID-19 in India: State-wise Analysis and Prediction

View ORCID ProfilePalash Ghosh, Rik Ghosh, Bibhas Chakraborty
doi: https://doi.org/10.1101/2020.04.24.20077792
Palash Ghosh
1Department of Mathematics, Indian Institute of Technology Guwahati, India
2Centre for Quantitative Medicine, Duke-NUS Medical School, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Palash Ghosh
  • For correspondence: palash.ghosh@iitg.ac.in
Rik Ghosh
1Department of Mathematics, Indian Institute of Technology Guwahati, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bibhas Chakraborty
2Centre for Quantitative Medicine, Duke-NUS Medical School, Singapore
3Department of Statistics and Applied Probability, National University of Singapore
4Department of Biostatistics and Bioinformatics, Duke University, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Coronavirus disease 2019 (COVID-19), a highly infectious disease, was first detected in Wuhan, China, in December 2019. The disease has spread to 212 countries and territories around the world and infected (confirmed) more than three million people. In India, the disease was first detected on 30 January 2020 in Kerala in a student who returned from Wuhan. The total (cumulative) number of confirmed infected people is more than 37000 till now across India (3 May 2020). Most of the research and newspaper articles focus on the number of infected people in the entire country. However, given the size and diversity of India, it may be a good idea to look at the spread of the disease in each state separately, along with the entire country. For example, currently, Maharashtra has more than 10000 confirmed cumulative infected cases, whereas West Bengal has less than 800 confirmed infected cases (1 May 2020). The approaches to address the pandemic in the two states must be different due to limited resources. In this article, we will focus the infected people in each state (restricting to only those states with enough data for prediction) and build three growth models to predict infected people for that state in the next 30 days. The impact of preventive measures on daily infected-rate is discussed for each state.

Highlights of the Analysis

  • Data considered for analysis: up to 1 May 2020.

  • One model can mislead us. Here, we consider the exponential, the logistic and the SIS models along with daily infection-rate (DIR). We interpret the results jointly from all models rather than individually.

  • We expect DIR to be zero or negative to conclude that COVID-19 is not spreading in a state. Even a small positive DIR (say 0.01) indicates virus is spreading in the community. The virus can potentially increase the DIR anytime.

  • Severe: The states without a decreasing trend in DIR and near exponential growth in active infected cases are Maharashtra, Delhi, Gujarat, Madhya Pradesh, Andhra Pradesh, Uttar Pradesh, and West Bengal.

  • Moderate: The states with an almost decreasing trend in DIR and non-increasing growth in active infected cases are Tamil Nadu, Rajasthan, Punjab and Bihar.

  • Controlled: The states with a decreasing trend in DIR and decreasing growth in active infected cases in the last few days are Kerala, Haryana, Jammu and Kashmir, Karnataka, and Telangana.

  • States with non-decreasing DIR need to do much more in terms of the preventive measures immediately to combat the COVID-19 pandemic. On the other hand, the states with decreasing DIR can maintain the same status to see the DIR become zero or negative for consecutive 14 days to be able to declare the end of the pandemic.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No external funding was received.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

I have used publicly available data for this article. The data source has been mentioned in the article. Here, I put the links again: The three primary sources of the data are the Ministry of Health and Family Welfare, India (https://www.mohfw.gov.in), https://www.covid19india.org/, and Wikipedia (https://en.wikipedia.org/wiki/2020_coronavirus_pandemic_in_India#Statistics).

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted May 19, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
COVID-19 in India: State-wise Analysis and Prediction
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
COVID-19 in India: State-wise Analysis and Prediction
Palash Ghosh, Rik Ghosh, Bibhas Chakraborty
medRxiv 2020.04.24.20077792; doi: https://doi.org/10.1101/2020.04.24.20077792
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
COVID-19 in India: State-wise Analysis and Prediction
Palash Ghosh, Rik Ghosh, Bibhas Chakraborty
medRxiv 2020.04.24.20077792; doi: https://doi.org/10.1101/2020.04.24.20077792

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (214)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1090)
  • Dentistry and Oral Medicine (194)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (497)
  • Epidemiology (9746)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2298)
  • Geriatric Medicine (221)
  • Health Economics (461)
  • Health Informatics (1548)
  • Health Policy (729)
  • Health Systems and Quality Improvement (600)
  • Hematology (236)
  • HIV/AIDS (500)
  • Infectious Diseases (except HIV/AIDS) (11618)
  • Intensive Care and Critical Care Medicine (615)
  • Medical Education (236)
  • Medical Ethics (67)
  • Nephrology (256)
  • Neurology (2136)
  • Nursing (133)
  • Nutrition (332)
  • Obstetrics and Gynecology (424)
  • Occupational and Environmental Health (516)
  • Oncology (1171)
  • Ophthalmology (363)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (144)
  • Palliative Medicine (50)
  • Pathology (308)
  • Pediatrics (692)
  • Pharmacology and Therapeutics (298)
  • Primary Care Research (265)
  • Psychiatry and Clinical Psychology (2168)
  • Public and Global Health (4640)
  • Radiology and Imaging (775)
  • Rehabilitation Medicine and Physical Therapy (450)
  • Respiratory Medicine (621)
  • Rheumatology (273)
  • Sexual and Reproductive Health (224)
  • Sports Medicine (208)
  • Surgery (250)
  • Toxicology (42)
  • Transplantation (120)
  • Urology (94)